Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Paul E. Phillips"'
Autor:
ANDRAS PERL, Hajra Tily, Zhi-wei Lai, Julie Yu, Stephen V Faraone, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Maha Dawood, Ricardo Garcia, Lisa Francis, Paul E Phillips
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/0cef401f7fc543deb878c26431ce792f
Autor:
Zhi-Wei Lai, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Julie Yu, Maha Dawood, Ricardo Garcia, Hajra Tily, Lisa Francis, Stephen V Faraone, Paul E Phillips, Andras Perl
Publikováno v:
2022 Lupus 21st Century Encore.
Autor:
Paul E. Phillips, Andras Perl, Ricardo Garcia, Zhi-Wei Lai, Ryan Kelly, Ashwini Shadakshari, Lisa Francis, Julie Yu, Ivan Marchena, Hajra Tily, Stephen V. Faraone, Maha Dawood, Thomas Winans
Publikováno v:
The Lancet. 391:1186-1196
Summary Background Patients with systemic lupus erythematosus have T-cell dysfunction that has been attributed to the activation of the mammalian target of rapamycin (mTOR). Rapamycin inhibits antigen-induced T-cell proliferation and has been develop
Autor:
Paul E. Phillips, Ryan Kelly, Zhi-Wei Lai, Lisa Francis, Andras Perl, Maha Dawood, Julie Yu, Ricardo Garcia, Thomas Winans, Stephen V. Faraone, Ashwini Shadakshari, Hajra Tily, Ivan Marchena
Publikováno v:
Big Data Analyses.
Background Systemic lupus erythematosus (SLE) patients exhibit T-cell dysfunction that has been attributed to mechanistic target of rapamycin activation. Therefore, safety, tolerance, and efficacy of rapamycin were examined in a prospective biomarker
Autor:
Andras Perl, Paul E. Phillips, Zhi-Wei Lai, Ryan Kelly, John M. Asara, Zachary Oaks, Robert Hanczko, Rebecca Borsuk
Publikováno v:
Metabolomics. 11:1157-1174
Systemic lupus erythematosus (SLE) patients exhibit depletion of the intracellular antioxidant glutathione and downstream activation of the metabolic sensor, mechanistic target of rapamycin (mTOR). Since reversal of glutathione depletion by the amino
Autor:
Adam Bartos, Eduardo Bonilla, Brandon Clair, Jianghong Yu, Andras Perl, Paul E. Phillips, Hajra Tily, Edward Doherty, Tiffany Caza, Ricardo Garcia, Stephen V. Faraone, Irene Ramos, Ioana L. Coman, Zhi-Wei Lai, John R. Jimah, Robert Hanczko, Lisa Francis, Maha Dawood, Gabriella Miklossy
Publikováno v:
Arthritis & Rheumatism. 64:2937-2946
Objective Systemic lupus erythematosus (SLE) patients exhibit T cell dysfunction, which can be regulated through mitochondrial transmembrane potential (Δψm) and mammalian target of rapamycin (mTOR) by glutathione (GSH). This randomized, double-blin
Publikováno v:
The Lancet. 392:734
Publikováno v:
Current Opinion in Rheumatology. 22:483-492
Purpose of review Genetic and environmental factors influence the development of systemic lupus erythematosus (SLE). Endogenous retroviruses (ERVs) are proposed as a molecular link between the human genome and environmental factors, such as viruses,
Autor:
Werner Müller-Esterl, Andras Perl, Eduardo Bonilla, Stefanie Oess, David Fernandez, Paul E. Phillips, Frank A. Middleton, Mary K. Crow, Sanjay K. Banerjee, Tiffany Telarico, Qing Li
Publikováno v:
The Journal of Immunology. 182:2063-2073
Persistent mitochondrial hyperpolarization (MHP) and enhanced calcium fluxing underlie aberrant T cell activation and death pathway selection in systemic lupus erythematosus. Treatment with rapamycin, which effectively controls disease activity, norm
Autor:
David Fernandez, György Nagy, Tiffany Telarico, Agnes Koncz, Paul E. Phillips, Péter Gergely, Eduardo Bonilla, Edward Doherty, Andras Perl
Publikováno v:
Autoimmunity. 41:287-297
Genetic and environmental factors are believed to influence development of systemic lupus erythematosus (SLE). Endogenous retroviruses (ERV) correspond to the integrated proviral form of infectious retroviruses, which are trapped within the genome du